Page 266 - 82_ex2

Rol of gut microbiota in obesity
metagenomic analysis in humanized gnotobiotic mice.
Sci Transl Med 2009; 1: 6ra14.
123.Schwiertz A, Taras D, Schafer K, Beijer S. et al.
Microbiota and SCFA in lean and overweight healthy
subjects. Obesity (Silver Spring) 2010; 18: 190-95.
124.Vrieze A, Van Nood E, Holleman F, Salojarvi J. et al.
Transfer of intestinal microbiota from lean donors
increases insulin sensitivity in individuals with
metabolic syndrome. Gastroenterology 2012; 143:
913-16 e917.
125.Walker AW, Ince J, Duncan SH, Webster LM. et al.
Dominant and diet-responsive groups of bacteria
within the human colonic microbiota. ISME 2011; J 5:
220-30.
126.Greenblum S, Carr R, Borenstein E. Extensive strain-
level copy-number variation across human gut
microbiome species. Cell 2015; 160: 583-94.
127.Consortium T. Structure, function and diversity of the
healthy human microbiome. Nature 2012; 486: 207-
14.
128.Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK,
Knight R. Diversity, stability and resilience of the
human gut microbiota. Nature 2012; 489: 220-230.
129.Villanueva-Millan MJ, Perez-Matute P, Oteo JA. Gut
microbiota: a key player in health and disease. A
review focused on obesity. J Physiol Biochem. 2015;
71: 509-25.
130.Degnan PH, Taga ME, Goodman AL. Vitamin B12 as
a modulator of gut microbial ecology. Cell Metab
2014; 20: 769-78.
131.LeBlanc JG, Milani C, de Giori GS, Sesma F. et al.
Bacteria as vitamin suppliers to their host: a gut
microbiota perspective. Curr Opin Biotechnol 2013;
24: 160-8.
132.Hill MJ. Intestinal flora and endogenous vitamin
synthesis. Eur J Cancer Prev 6 Suppl 1997; 1: S43-5.
133.Gill SR, Pop M, Deboy RT, Eckburg PB. et al.
Metagenomic analysis of the human distal gut
microbiome. Science 2006; 312: 1355-9.
134.Tremaroli V, Backhed F. Functional interactions
between the gut microbiota and host metabolism.
Nature 2012; 489: 242-9.
135.Cummings JH, Macfarlane GT. The control and
consequences of bacterial fermentation in the human
colon. J Appl Bacteriol 1991; 70: 443-59.
136.Silvester KR, Englyst HN, Cummings JH. Ileal
recovery of starch from whole diets containing
resistant starch measured in vitro and fermentation of
ileal effluent. Am J Clin Nutr 1995; 62: 403-11.
137.Asp NG. Resistant starch--an update on its
physiological effects. Adv Exp Med Biol 1997; 427:
201-10.
138.Keenan MJ, Zhou J, Hegsted M, Pelkman C. et al.
Role of resistant starch in improving gut health,
adiposity, and insulin resistance. Adv Nutr 2015; 6:
198-205.
139.Chassard C, Delmas E, Robert C, Bernalier-Donadille
A. The cellulose-degrading microbial community of
the human gut varies according to the presence or
@Real Academia Nacional de Farmacia. Spain
absence of methanogens. FEMS Microbiol Ecol 2010;
74: 205-13.
140.Lairon D, Bertrais S, Vincent S, Arnault N. et al.
Dietary fibre intake and clinical indices in the French
Supplementation en Vitamines et Mineraux
AntioXydants (SU. IMAX) adult cohort. Proc Nutr
Soc 2003; 62: 11-5.
141.Chassard C, Delmas E, Robert C, Lawson PA,
Bernalier-Donadille A. Ruminococcus
champanellensis sp. nov, a cellulose-degrading
bacterium from human gut microbiota. Int J Syst Evol
Microbiol 2012; 62: 138-43.
142.Bindels LB, Delzenne NM, Cani PD, Walter J.
Towards a more comprehensive concept for
prebiotics. Nat Rev Gastroenterol Hepatol. 2015; 12:
303–10.
143.Corzo N, Alonso JL, Azpiroz F, Calvo MA. et al.
[Prebiotics: concept, properties and beneficial effects].
Nutr Hosp 31 Suppl 2015; 1: 99-118.
144.Macfarlane S, Macfarlane GT. Regulation of short-
chain fatty acid production. Proc Nutr Soc 2003; 62:
67-72.
145.Neis EP, Dejong CH, Rensen SS. The role of
microbial amino acid metabolism in host metabolism.
Nutrients 2015; 7: 2930-46.
146.Miller TL, Wolin M. Fermentations by saccharolytic
intestinal bacteria. Am J Clin Nutr 1979; 32: 164-72.
147.Duncan SH, Louis P, Thomson JM, Flint HJ. The role
of pH in determining the species composition of the
human colonic microbiota. Environ Microbiol 2009;
11: 2112-22.
148.Bergman EN. Energy contributions of volatile fatty
acids from the gastrointestinal tract in various species.
Physiol Rev 1990; 70: 567-90.
149.McNeil NI. The contribution of the large intestine to
energy supplies in man. Am J Clin Nutr 1984; 39:
338-42.
150.Canani RB, Costanzo MD, Leone L, Pedata M. et al.
Potential beneficial effects of butyrate in intestinal and
extraintestinal diseases. World J Gastroenterol 2011;
17: 1519-28.
151.Puddu A., Sanguineti R., Montecucco F., Viviani G.L.
Evidence for the gut microbiota short-chain fatty acids
as key pathophysiological molecules improving
diabetes. Mediators Inflamm: 2014; 162021.
152.Byrne CS, Chambers ES, Morrison DJ, Frost G. The
role of short chain fatty acids in appetite regulation
and energy homeostasis. Int J Obes 2015; 39: 1331-8.
153.Wolever TM, Brighenti F, Royall D, Jenkins AL,
Jenkins DJ. Effect of rectal infusion of short chain
fatty acids in human subjects. Am J Gastroenterol
1989; 84: 1027-33.
154.Velagapudi VR, Hezaveh R, Reigstad CS,
Gopalacharyulu P. et al. The gut microbiota
modulates host energy and lipid metabolism in mice. J
Lipid Res 2010; 51: 1101-12.
155.Nair S, Cope K, Risby TH, Diehl AM. Obesity and
female gender increase breath ethanol concentration:
potential implications for the pathogenesis of
255